Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer ; volume:9 ; number:1 ; day:11 ; month:8 ; year:2011 ; pages:1-10 ; date:12.2011
Journal of translational medicine ; 9, Heft 1 (11.8.2011), 1-10, 12.2011
- Urheber
-
Elfiky, Aymen A.
- Beteiligte Personen und Organisationen
-
Aziz, Saadia A.
Conrad, Patricia J.
Siddiqui, Summar
Hackl, Wolfgang
Maira, Michel
Robert, Camp L.
Kluger, Harriet M.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-9-133
- URN
-
urn:nbn:de:1111-2016041438238
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:48 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Elfiky, Aymen A.
- Aziz, Saadia A.
- Conrad, Patricia J.
- Siddiqui, Summar
- Hackl, Wolfgang
- Maira, Michel
- Robert, Camp L.
- Kluger, Harriet M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Molekulare Analyse des Phosphatidylinositol-3-Kinase(PI3K)-Signalwegs
NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity
Die Rolle des "Protein Associated with Myc" (PAM) bei der Regulation des "mammalian Target Of Rapamycin" (mTOR) Signalweges
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Molekulare Analyse des Phosphatidylinositol-3-Kinase(PI3K)-Signalwegs
NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity
Die Rolle des "Protein Associated with Myc" (PAM) bei der Regulation des "mammalian Target Of Rapamycin" (mTOR) Signalweges
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Molekulare Analyse des Phosphatidylinositol-3-Kinase(PI3K)-Signalwegs
NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity